Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression.
Tsambaos
D
D
Department of Dermatology, University of Patras, Greece.
Spiliopoulos
T
T
D000230:Adenocarcinoma; D003882:Dermatomyositis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D010051:Ovarian Neoplasms; D010257:Paraneoplastic Syndromes / Q000188:drug therapy; D017499:Porokeratosis / Q000139:chemically induced* / Q000628:therapy*
D008775:Methylprednisolone